Edition 9.0 ATI Review Module
Content Mastery Series
Latest Update 2026 WITH ALL 48 CHAPTERS
Total Questions 240 Multiple Choice
Sections 11 ATI-Aligned Content Domains
Chapters Covered All 48 Chapters of ATI Pharmacology Review Module
Question Format 4 Options (A-D), One Correct Answer
Cognitive Distribution 30% Recall / 50% Application / 20% Analysis
Question Style 75% Scenario-Based / 25% Direct Recall & Calculations
Rationale Format Detailed ATI-Specific Pharmacological Reasoning
Guideline Alignment 2026 ATI Content & NCLEX Test Plan Updates
Examination Instructions
• This test bank consists of 240 multiple-choice questions distributed across eleven ATI RN Pharmacology
Edition 9.0 content domains, covering all 48 chapters of the ATI Review Module.
• Each question has four options (A, B, C, D) with exactly one correct answer.
• Correct answers are identified and accompanied by detailed ATI-specific rationales explaining both why the
correct option is right and why the distractors are wrong.
• Cognitive complexity spans recall (30%), application (50%), and analysis (20%) per ATI Content Mastery
Series framework.
• Scenario-based questions (75%) require application of nursing pharmacology principles to clinical situations,
integrating medication classification, mechanism of action, adverse effects, nursing considerations, and safety
,ATI RN Pharmacology Edition 9.0 | Latest Update 2026 Content Mastery Series | All 48 Chapters
principles.
• Content aligns with 2026 ATI Content Mastery Series and NCLEX test plan updates, including current ATI
testing strategies and high-alert medication safety standards.
Prepared for ATI RN Pharmacology Content Mastery Candidates
2026 Latest Update
Page 2 | 240-Question Test Bank
, ATI RN Pharmacology Edition 9.0 | Latest Update 2026 Content Mastery Series | All 48 Chapters
SECTION 1: PHARMACOLOGY FOUNDATIONS AND SAFE MEDICATION
ADMINISTRATION
Chapters 1-5 (Q1-Q15)
Q1: A nurse is preparing to administer medications to a patient. Which of the following represents the 'Six
Rights' of medication administration?
A. Right patient, right medication, right dose, right route, right time, right documentation [CORRECT]
B. Right patient, right medication, right doctor, right pharmacy, right room, right chart
C. Right diagnosis, right medication, right dose, right nurse, right time, right family
D. Right patient, right syringe, right vial, right label, right pharmacy, right documentation
Correct Answer: A
Rationale:
The Six Rights of medication administration are: right patient (using two identifiers), right medication, right dose,
right route, right time, and right documentation. Some institutions add a 7th-9th right (right reason, right response,
right to refuse). Options B, C, and D include incorrect elements (doctor, family, room, vial). ATI emphasizes these
rights as foundational safety checks.
Q2: A patient receives a medication that is an agonist at the beta-1 receptor. Which pharmacodynamic effect
is expected?
A. Decreased heart rate and contractility
B. Increased heart rate and contractility [CORRECT]
C. Bronchodilation
D. Vasodilation
Correct Answer: B
Rationale:
Beta-1 agonists (e.g., dobutamine, dopamine at low doses) stimulate beta-1 receptors in the heart, increasing heart rate
(chronotropy) and contractility (inotropy). Option A describes beta-1 antagonist (beta-blocker) effects. Option C
describes beta-2 agonist effects (e.g., albuterol). Option D describes alpha-1 antagonist or nitrate effects. Receptor
selectivity determines pharmacologic effects.
Q3: A nurse is teaching a patient about a medication with a narrow therapeutic index. Which statement by the
patient indicates understanding?
A. 'I can adjust my dose if I feel well.'
B. 'I will need regular blood tests to monitor my drug levels and watch for toxicity.' [CORRECT]
C. 'I don't need to worry about side effects.'
D. 'I can take this medication with grapefruit juice.'
Correct Answer: B
Rationale:
A narrow therapeutic index (e.g., digoxin, warfarin, lithium) means the toxic dose is close to the therapeutic dose,
requiring serum drug level monitoring. Option A is unsafe—dose adjustments require provider orders. Option C is
incorrect—narrow TI drugs have significant toxicity risk. Option D is unsafe—grapefruit inhibits CYP3A4 and
affects many drugs. ATI emphasizes monitoring for narrow TI drugs.
Page 3 | 240-Question Test Bank